Carmignac Gestion Generation Bio Co. Transaction History

Carmignac Gestion

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$5.99 - $24.97 $8.82 Million - $36.8 Million	-1,472,624 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$20.0 - $27.43 $18,000 - $24,687	-900 Reduced 0.06%	1,472,624 $36.9 Million
Q2 2021 Aug 13, 2021	SELL	$24.34 - $38.34 $1.51 Million - $2.39 Million	-62,212 Reduced 4.05%	1,473,524 $39.6 Million
Q1 2021 May 14, 2021	BUY	$24.74 - $40.2 $38 Million - $61.7 Million	1,535,736 New	1,535,736 $43.7 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $63.1M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.